Pricing Log in Create free account

Definium Therapeutics, Inc. (DFTX) vs Edgewise Therapeutics, Inc. (EWTX)

Definium Therapeutics, Inc. and Edgewise Therapeutics, Inc. are both Biotechnology companies. Definium Therapeutics, Inc. is the larger, with a market value of $4.6B against $4.2B — 1.1× the size. Across the 9 metrics below, Edgewise Therapeutics, Inc. leads on 7 and Definium Therapeutics, Inc. on 2.

Valuation

Metric DFTX EWTX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 3.87 8.94 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (10.69%) (4.97%) (33.15%)
Free cash flow yield (4.73%) (3.97%) (25.50%)

Profitability

Metric DFTX EWTX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (64.09%) (38.03%) (56.36%)
Return on assets (51.35%) (36.09%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DFTX EWTX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (33.77%) (12.41%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DFTX EWTX Biotechnology median
Debt to equity 0.04 0.00 0.00
Current ratio 6.95 16.24 4.72
Net debt to EBITDA 2.21 2.69 0.96

Dividend

Metric DFTX EWTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DFTX EWTX Biotechnology median
Market cap 4.60b 4.15b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack